Cancer cells undergoing and molecular EMT exhibit morphological changes, such as decreased expression of epithelial markers (e.g., E‐cadherin, zonula occludens‐1, and occluding) and increased expression of mesenchymal markers (e.g., N‐cadherin protein, fibroblast‐specific protein 1, and fibronectin).33, 34. Here, CDH1 is linked to cancer.